BioNTech Acquires Biotheus to Strengthen Oncology Pipeline with Bispecific Antibody Asset BNT327/PM8002

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) announced the signing of a definitive agreement for...

November 14, 2024 | Thursday | News
AstraZeneca and Amgen’s Tezspire Shows Promising Phase III WAYPOINT Trial Results in Chronic Rhinosinusitis with Nasal Polyps

Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]) showed that...

November 11, 2024 | Monday | News
Headway Joins National Quality Forum's Aligned Innovation Initiative to Redefine Behavioral Health Quality Measures

Headway, the company building a new mental healthcare system, announced its participation in the Aligned Innovation initiative, a groundbreaking cross-indu...

November 06, 2024 | Wednesday | News
Acadia Pharmaceuticals to Sell Rare Pediatric Disease Priority Review Voucher for $150 Million

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced that it entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority...

November 06, 2024 | Wednesday | News
Abzena Expands Quality Control Testing Capabilities at San Diego Facility, Elevating Biologics Manufacturing and Microbiology Standards

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates announced a significant expansion in their quality control (QC) test...

October 31, 2024 | Thursday | News
AbbVie to Acquire Aliada Therapeutics for $1.4 Billion, Advancing Alzheimer's Research

AbbVie (NYSE: ABBV) and Aliada Therapeutics announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology company advancing...

October 29, 2024 | Tuesday | News
Grifols Partners with BARDA to Develop Eye Drops for Sulfur Mustard Ocular Injury

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has established a...

October 23, 2024 | Wednesday | News
Eisai and Biogen Seek Reconsideration of Lecanemab Registration Decision in Australia

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusett...

October 17, 2024 | Thursday | News
AtomVie and Radiopharm Ventures Partner to Develop Targeted Radiopharmaceutical 177Lu-BetaBart

AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), has entered into an agreeme...

October 16, 2024 | Wednesday | News
Sygnature Discovery Appoints Amira Modi as New Chief Operating Officer and Board Member

World-leading contract research organization (CRO) Sygnature Discovery is delighted to announce the appointment of Amira Modi as its new Chief Operating ...

October 04, 2024 | Friday | News
Thermo Fisher Scientific Launches Global Adolescent Atopic Dermatitis Registry to Advance Treatment Research

Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD)...

October 01, 2024 | Tuesday | News
Thermo Fisher Scientific Expands OSD Capabilities with $22 Million Investment to Accelerate Drug Development

To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutical companies, Thermo Fisher Scien...

September 27, 2024 | Friday | News
Shuttle Pharmaceuticals Expands Phase 2 Glioblastoma Trial with Two Additional Sites

Shuttle Pharmaceuticals Holdings, a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients tr...

September 17, 2024 | Tuesday | News
Scantox Group Acquires UK-Based Gentronix to Expand Genetic Toxicology Services

Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Resear...

September 09, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close